Ligand Pharmaceuticals reported $17K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 3.06M 107K
Anika Therapeutics ANIK:US USD 146K 0
Arrowhead Research ARWR:US USD 199K 1000
Baxter International BAX:US USD 683M 0
Clovis Oncology CLVS:US USD 145K 1000
Enanta Pharmaceuticals ENTA:US USD 209K 1000
Endo International Ordinary Shares ENDP:US USD 63K 3K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Glaxosmithkline GSK:US GBP 1.35B 0
Harsco HSC:US USD 145.45M 58K
Heron Therapeutics HRTX:US USD 1.19M 163K
Immunogen IMGN:US USD 2.26M 52K
Insmed INSM:US USD 1.36M 140K
Lannett LCI:US USD 43K 0
Macrogenics MGNX:US USD 617K 2K
Pacira Pharmaceuticals PCRX:US USD 46K 0
Rigel Pharmaceuticals RIGL:US USD 174K 1000
Sangamo Biosciences SGMO:US USD 1.67M 49K
Spectrum Pharmaceuticals SPPI:US USD 203K 18K
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Veracyte VCYT:US USD 72K 0